Researchers have identified a gene variant that is protective against both late-onset Alzheimer's disease and age-related cognitive decline. Beyond its scientific novelty, the work provides a proof of concept that inhibiting beta-secretase, or BACE1, can be effective against both Alzheimer's disease and age-related cognitive decline – because that is the net effect of the variant that senior author Kari Stefansson and his team have identified.